Roger Eaton, Ph.D. has brought many lasting contributions to the newborn screening research community. He leads the UMMS New England Newborn Screening Program (NENSP) as director and has been with the program as a researcher since 1991. While at NENSP, Dr. Eaton and his team allowed Massachusetts to be one of the first states to apply tandem mass spectrometry their newborn screening tests. Among their many accomplishments, Dr. Eaton’s team has improved state-regulated newborn screening with the addition of succinylacetone screening in 2008, as well as screening for severe combined immunodeficiency in 2009.
Dr. Eaton is an associate professor in the department of pediatrics at the University Of Massachusetts School Of Medicine. He received his master’s and Ph.D. from the State University of New York and went on to do his postdoctoral work at Harvard Medical School where he broadened his background in microbiology and immunology. He has authored or co-authored over sixteen articles in the last ten years on many subjects that are relevant to newborn screening such as long-term follow-up for individuals diagnosed with newborn screening conditions, or the effects of expanded newborn screening for biochemical genetic disorders.
Dr. Eaton is a member of the Association of Public Health Laboratories (APHL) and the International Society of Newborn Screening (ISNS) and serves on a number of workgroups and committees. NBSTRN is pleased to congratulate Dr. Eaton on all of his efforts to newborn screening!